US Patent 10022379 | Patents | Expiry | Expiration | Dates

BOEHRINGER INGELHEIM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10022379

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-04-02

Patent Use Code

U-2339

Delist Requested

Application Number

201281

Patent Use Description

Product Number

3

BOEHRINGER INGELHEIM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10022379

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-04-02

Patent Use Code

U-2339

Delist Requested

Application Number

201281

Patent Use Description

Product Number

1

BOEHRINGER INGELHEIM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10022379

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-04-02

Patent Use Code

U-2339

Delist Requested

Application Number

201281

Patent Use Description

Product Number

2

BOEHRINGER INGELHEIM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10022379

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-04-02

Patent Use Code

U-2339

Delist Requested

Application Number

208026

Patent Use Description

Product Number

2

BOEHRINGER INGELHEIM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10022379

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-04-02

Patent Use Code

U-2339

Delist Requested

Application Number

208026

Patent Use Description

Product Number

1

BOEHRINGER INGELHEIM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10022379

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2029-04-02

Patent Use Code

U-2732

Delist Requested

Application Number

212614

Patent Use Description

Product Number

4

BOEHRINGER INGELHEIM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10022379

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2029-04-02

Patent Use Code

U-2732

Delist Requested

Application Number

212614

Patent Use Description

Product Number

3

BOEHRINGER INGELHEIM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10022379

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2029-04-02

Patent Use Code

U-2732

Delist Requested

Application Number

212614

Patent Use Description

Product Number

2

BOEHRINGER INGELHEIM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Supporting Information : Click here to upload a PDF

US Patent Number

10022379

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2029-04-02

Patent Use Code

U-2732

Delist Requested

Application Number

212614

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10022379

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

2029-04-02

U-2339

3

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

2029-04-02

U-2339

1

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

2029-04-02

U-2339

2

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

2029-04-02

U-2339

2

LINAGLIPTIN; METFORMIN HYDROCHLORIDE

2029-04-02

U-2339

1

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Y

2029-04-02

U-2732

4

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Y

2029-04-02

U-2732

3

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Y

2029-04-02

U-2732

2

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Y

2029-04-02

U-2732

1